{
  "id": 6198,
  "url": "https://nnemf.org/research/6198-stability-of-solutions-of-doxorubicin-and-epirubicin-in",
  "title": "Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20 degrees C and thawing by microwave radiation.",
  "authors": [
    "L Keusters",
    "L M Stolk",
    "R Umans",
    "P Van Asten"
  ],
  "journal": "Pharmaceutisch weekblad. Scientific edition",
  "year": "1986",
  "doi": "10.1007/bf01959778",
  "pmid": "3461424",
  "abstract": "Doxorubicin and epirubicin solutions in plastic minibags for intravesical use were stored at -20 degrees C and thawed at room temperature or by microwave radiation. Concentrations were measured with HPLC and TLC. Doxorubicin and epirubicin solutions could be frozen and stored at -20 degrees C during at least two and four weeks, respectively, and subsequently thawed without loss of content. When the thawed doxorubicin solutions were refrozen and thawed again five weeks later, only a slight decrease of content was measured.",
  "effect": "no_effect",
  "evidence": "insufficient",
  "extraction": {
    "studyType": "other",
    "studyTypeLabel": "Other",
    "effectDirection": "no_effect",
    "evidenceLabel": "Insufficient",
    "population": "—",
    "sampleSize": "—",
    "exposure": "microwave",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Doxorubicin and epirubicin solutions stored at -20°C and thawed either at room temperature or by microwave radiation showed no loss of content after at least 2 weeks (doxorubicin) and 4 weeks (epirubicin). Refreezing and re-thawing doxorubicin five weeks later resulted in only a slight decrease in content.",
    "outcomes": [
      "Drug concentration/content stability after freezing and thawing (doxorubicin",
      "epirubicin)"
    ],
    "limitations": [
      "No sample size reported in abstract",
      "Microwave exposure parameters (e.g.",
      "frequency",
      "power",
      "duration) not reported",
      "Study focuses on pharmaceutical stability rather than biological/health outcomes"
    ],
    "keywords": [
      "doxorubicin",
      "epirubicin",
      "intravesical",
      "plastic minibags",
      "-20°C storage",
      "freezing",
      "thawing",
      "microwave radiation",
      "HPLC",
      "TLC",
      "stability"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"other\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"microwave radiation (thawing)\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": null,\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Drug concentration/content stability after freezing and thawing (doxorubicin, epirubicin)\"\n  ],\n  \"main_findings\": \"Doxorubicin and epirubicin solutions stored at -20°C and thawed either at room temperature or by microwave radiation showed no loss of content after at least 2 weeks (doxorubicin) and 4 weeks (epirubicin). Refreezing and re-thawing doxorubicin five weeks later resulted in only a slight decrease in content.\",\n  \"effect_direction\": \"no_effect\",\n  \"limitations\": [\n    \"No sample size reported in abstract\",\n    \"Microwave exposure parameters (e.g., frequency, power, duration) not reported\",\n    \"Study focuses on pharmaceutical stability rather than biological/health outcomes\"\n  ],\n  \"evidence_strength\": \"insufficient\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"doxorubicin\",\n    \"epirubicin\",\n    \"intravesical\",\n    \"plastic minibags\",\n    \"-20°C storage\",\n    \"freezing\",\n    \"thawing\",\n    \"microwave radiation\",\n    \"HPLC\",\n    \"TLC\",\n    \"stability\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/3461424/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=6198",
  "updated": "2026-02-16 01:23:11"
}